Keith D. Wilner
Keith D. Wilner publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.
- World rank
- #143,525 of 7,710,434 ranked researchers
- Rank in United States
- #54,268 of 1,627,098
- Works
- 269
- Citations
- 31k
- Citations per work
- 116.9
What does Keith D. Wilner research?
Keith D. Wilner's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences15858.9%
- Medicine15858.9%
- Everything else8832.8%
- Life Sciences228.3%
- 1Pulmonary and Respiratory Medicine32% of their works
- 2Oncology20% of their works
- 3Molecular Biology6% of their works
- 4Psychiatry and Mental health5% of their works
- 5Cancer Research3% of their works
- 6Pediatrics, Perinatology and Child Health3% of their works
Research topics
Which keywords describe Keith D. Wilner's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Adjuvant Therapy, Genomic Profiles and Small-Cell Lung Cancer.
- Pharmacogenetics
- MAP Kinase
- Endoscopic Resection
- BRAF gene
- KRAS Mutations
- Lung Cancer
- Small-Cell Lung Cancer
- Adjuvant Therapy
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- EGFR Mutations
- Genomic Profiles
- CT Screening
- Cetuximab
- Antipsychotic Drugs
- Cytochrome P450
- Gastric Cancer
- Neurocognitive Deficits
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Clinical Trials1572 topics
- Targeted Therapy1572 topics
- Chemotherapy1274 topics
- ALK Inhibitors1161 topic
- EGFR Mutations1161 topic
- Adjuvant Therapy532 topics
- Genomic Profiles411 topic
- Small-Cell Lung Cancer411 topic
- CT Screening401 topic
- Lung Cancer401 topic
- Cetuximab331 topic
- KRAS Mutations331 topic
- Antipsychotic Drugs131 topic
- BRAF gene131 topic
- Cytochrome P450131 topic
- Endoscopic Resection131 topic
- Gastric Cancer131 topic
- MAP Kinase131 topic
- Neurocognitive Deficits131 topic
- Pharmacogenetics131 topic
Where does Keith D. Wilner work?
Keith D. Wilner's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does Keith D. Wilner have?
OpenAlex counts 269 works and 31,459 citations for Keith D. Wilner, an h-index of 60, ranking #143,525 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Keith D. Wilner. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.